Burgermenu-Close

YOUR
Search

    Robert Schmid
    ADVANT Beiten - Berlin
    Rechtsanwalt
    Senior Associate

    Robert Schmid

    ADVANT Beiten - Berlin
    Rechtsanwalt
    Senior Associate

    LANGUAGES

    English / German

    Practice Areas

    Contract & Commercial Law - Corporate/M&A

    Sectors

    Healthcare - Private Clients & Foundations

    Contacts

    T : +49 30 26471-262

    F : +49 30 26471-246

    Robert.Schmid@advant-beiten.com

    vCard Print

    Expertise

    Robert Schmid is Senior Associate at ADVANT Beiten's Berlin office and member of the Corporate / M&A practice group. His area of expertise comprises mergers & acquisitions, corporate and transformation law as well as the law governing groups. He particularly advises his national and international clients on transactions and restructurings, as well as on cormercial law.

    Robert Schmid studied law at the Europa-Universität Viadrina Frankfurt (Oder) and was admitted to the German Bar in 2018. Prior of joining ADVANT Beiten, Mr Schmid worked in the corporate tax team of an international accounting firm. He has been working with ADVANT Beiten since 2018.

    Publications

    Vorträge/Online-Seminare:

    Meldepflichten bei Auslandszahlungen, Online-Seminarreihe - Auf den Punkt, 01. Juli 2020

    Articles

    First German Cannabis Bill – Half Baked? – Implications for social clubs and commerce
    The German health minister Mr. Lauterbach has presented - as announced - a first draft of a law that is to further open the cannabis market. The government is still discussing the bill internally; the bill…
    Read more
    Licensed Stores vs. Social Clubs – Germany up in smoke?
    In the coalition agreement of 2021, the coalition parties agreed on the introduction of controlled sale of cannabis for consumption to adults in licensed shops. The decisive factors here should be to contr…
    Read more
    Notification obligations under foreign trade law – the risks and stumbling blocks for M&A transactions
    The legal due diligence assessment carried out as part of an M&A transaction provides a careful assessment of the legal risks associated with the target and is an indispensable element of every transaction…
    Read more
    Update: Entry into force of the Medical Need Health Care Assurance Regulation ("MedBVSV") of the Federal Ministr…
    The Health Care Assurance Regulation MedBVSV which was announced on 14 April 2020 (please also see our post dated 17 April 2020) entered into force on 27 May 2020 (LINK to MedBVSV). The Regulation devia…
    Read more
    Second Act for the Protection of the Population in the Event of an Epidemic Situation of National Significance
    Subsequent to the "Act for the Protection of the Population in the Event of an Epidemic Situation of National Significance" dated 25 March 2020 (see our blog post dated 30 March 2020), the German Parliamen…
    Read more
    Digital Health Applications Ordinance – DiGAV of 21 April 2020
    To contain the spread of the coronavirus, the use of applications (apps) that are used on smartphones or smart watches has been proposed frequently. It is not least this consideration that suggests that di…
    Read more
    Update: Entry into Force of the SARS-CoV-2 Pharmaceuticals Supply Regulation of the Federal Ministry of Health (…
    The SARS-CoV-2 drug supply regulation announced on 8 April 2020 (see our Article of 17 April 2020) came into force on 22 April 2020 (SARS-CoV-2-Pharmaceuticals Supply Regulation). The Regulation deviate…
    Read more
    Planned Enactment of SARS-CoV-2-Pharmaceuticals Supply Regulation and Medical Needs Supply Securing Regulation
    With this article we would like to inform you about further facilitations concerning the marketing of medical products and personal protective equipment ("PPE"). See also our articles of 1.April 2020 (LINK…
    Read more
    Update on the Placing on the Market of Medical Devices and Personal Protective Equipment (PPE) such as (Respirat…
    In our posts dated 1 April 2020 (LINK) and dated 2 April 2020 (LINK) we informed about the placing on the market of medical devices and personal protective equipment in the context of the corona crisis. Ta…
    Read more
    The Placing on the Market of Personal Protective Equipment such as (Respiratory) Masks
    In the course of the spread of the disease COVID-19, caused by the virus SARS-CoV-2, there is currently a high demand especially for products such as (respiratory) protective masks. This raises the questio…
    Read more
    Facilitating the placing on the market of medical devices in the course of the coronavirus crisis
    In the course of the spread of the COVID-19 disease, caused by the virus SARS-CoV-2, there is an increasing shortage of medical devices. There is also an acute need for newly developed medical devices, suc…
    Read more
    Legislative packages to support the public health system in managing the coronavirus epidemic
    On 25 March 2020 the German Bundestag adopted draft bills proposed by the parliamentary groups of the Christian Democratic Union (CDU/CSU) and the Social Democratic Party (SPD) for the "COVID19 Hospital Re…
    Read more

    Press

    ADVANT Beiten advises Cipla (EU) Limited on its investment in Ethris GmbH
    Berlin, 25 January 2023 – The international law firm ADVANT Beiten has provided comprehensive legal advice to Cipla (EU) Limited, a wholly-owned subsidiary of Cipla Limited (“Cipla”), headquartered in Mumb…
    Read more
    BEITEN BURKHARDT Assists vdek with Comprehensive Negotiations with Insolvency Administrator of AvP Deutschland …
    Berlin/Frankfurt, 19 July 2021 – The international commercial law firm BEITEN BURKHARDT has assisted and comprehensively advised the Association of Substitute Health Insurance Funds (Verband der Ersatzkass…
    Read more
    OUR OFFICES
    COOPERATION PARTNER
    BEITEN Consulting
    Imprint - Privacy Protection